PEPTONIC medical Aktie

Peptonic Medical AB engages in the development of oxytocin based products for the treatment of menopausal symptoms. It develops Vagitocin, which focuses on the treatment of vaginal atrophy. The company was founded by Kerstin Uvnas Moberg and Ronald Eric Long on December 2, 2008 and is headquartered in Bromma, Sweden.